...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Combo with Enzalutamide in Phase 2 Metastatic Prostate Cancer Clinical Trial and with Pfizer’s PARPi, talazoparib, in Phase 1b/2 Triple Negative Breast Cancer Trial

Free
Discussion Forum: Zenith Epigenetics
Author / Date /
Topic Title
Rating
Re
Last Post
3
0
Feb 20, 2020 02:24PM
Telepanel - Dec 10, 2019 03:57PM
24
7
Feb 16, 2020 07:16PM
Payzone - Feb 10, 2020 10:59AM
5
0
Feb 10, 2020 10:59AM
2
0
Feb 09, 2020 08:48AM
21
4
Feb 02, 2020 03:59PM
fuzzyjr - Jan 02, 2020 07:39PM
10
2
Jan 04, 2020 11:22AM
Payzone - Dec 20, 2019 11:17AM
30
4
Jan 01, 2020 12:32PM
rocketman2 - Dec 19, 2019 09:13AM
9
2
Dec 19, 2019 05:05PM
2
0
Dec 19, 2019 09:36AM
RVXoldtimer - Nov 21, 2019 09:20PM
11
0
Nov 21, 2019 09:20PM
Telepanel - Nov 21, 2019 12:54PM
43
7
Nov 21, 2019 02:47PM
jonzobot - Nov 20, 2019 11:19PM
9
2
Nov 21, 2019 10:51AM
BearDownAZ - Oct 31, 2019 09:01PM
66
14
Nov 20, 2019 01:15PM
3
2
Nov 18, 2019 05:09PM
imtesty - Nov 13, 2019 04:14AM
9
3
Nov 14, 2019 07:34AM
BearDownAZ - Nov 06, 2019 04:06PM
5
0
Nov 06, 2019 04:06PM
KOO-KOO2 - Nov 04, 2019 10:57AM
10
1
Nov 04, 2019 12:14PM
rocketman2 - Oct 31, 2019 09:17PM
4
0
Oct 31, 2019 09:17PM